Barytes is not like any other mineral with industrial applications. It is indispensable for oil and gas drilling, where it is ...
Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback